Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial | INTERNATIONAL JOURNAL OF CANCER |